CHAS HAYNES
![](http://www.evecon.com.br/bandeiras/eua.gif)
Chas Haynes, JD is the Executive Director of the Society for Neuro-Oncology, a position he has held since 2006. Mr. Haynes is responsible for the day-to-day operations of SNO, and works with the elected leadership to implement the Society’s strategic plan. He has over 25 years of experience in the leadership and operational management of non-profit medical associations. Mr. Haynes has a Bachelor of Arts degree from the University of Texas, Austin, and a Juris Doctor degree from the South Texas College of Law in Houston, Texas.
Confira a agenda de atividades
22 DE MARÇO | SEXTA-FEIRA
Room 1
15:50-17:30
PLENARY SESSION 2
Awake glioma surgery: technical evolutions and nuances
The role of liquid biopsy in neuro-oncology
How can NGS affect prognosis and treatment for diffuse gliomas?
Radiogenomics in gliomas
SNO Institutional Presentation
Moderator: Rodrigo Ferrari Fernandes Naufal (SP)
Moderator: Daniel Marques (DF)
Moderator: José Marcus Rotta (SP)
Awake glioma surgery: technical evolutions and nuances
Speaker: Lorenzo Bello (Itália)
The role of liquid biopsy in neuro-oncology
Speaker: Francisco Martínez Ricarte (Espanha)
How can NGS affect prognosis and treatment for diffuse gliomas?
Speaker: Roger Stüpp (Estados Unidos)
Radiogenomics in gliomas
Speaker: Rajan Jain (Estados Unidos)
SNO Institutional Presentation
Speaker: Chas Haynes (Estados Unidos)